A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris
Abroad (travel likely)RecruitingPHASE3
Conditions
Acne Vulgaris
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Galderma Research & Development Site #5378, Shanghai, Jing'an District, China
Contact: Principal Investigator (Leihong Xiang)